| P50 | author | Nicolas L Fawzi | Q51350563 |
| | Jeetain Mittal | Q59677099 |
| | Gregory L Dignon | Q88724372 |
| | Frank Shewmaker | Q88724373 |
| P2093 | author name string | Robert B Best | |
| | Robert N Cole | |
| | Veronica H Ryan | |
| | Kathleen A Burke | |
| | Robert O'Meally | |
| | Wenwei Zheng | |
| | Abigail M Janke | |
| | Alexander E Conicella | |
| | Shannon N Rhoads | |
| | Gül H Zerze | |
| | Zachary Monahan | |
| P2860 | cites work | Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS | Q24629495 |
| | A DNA-activated protein kinase from HeLa cell nuclei | Q24633308 |
| | A new subtype of frontotemporal lobar degeneration with FUS pathology | Q24647697 |
| | Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure | Q24676369 |
| | Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease | Q26753190 |
| | Yeast prions and human prion-like proteins: sequence features and prediction methods | Q26863334 |
| | Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation | Q27325625 |
| | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | Q27936710 |
| | Engineering enhanced protein disaggregases for neurodegenerative disease | Q28083809 |
| | Substrate specificities and identification of putative substrates of ATM kinase family members | Q28141080 |
| | Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis | Q28236796 |
| | Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 | Q28236805 |
| | Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization | Q28588090 |
| | Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels | Q29614781 |
| | Proteomics. Tissue-based map of the human proteome | Q29617248 |
| | Spectral density function mapping using 15N relaxation data exclusively | Q30193137 |
| | RNA seeds higher-order assembly of FUS protein | Q30457170 |
| | Nucleic acid-binding specificity of human FUS protein | Q30459673 |
| | Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion | Q30532680 |
| | Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose). | Q30663823 |
| | Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. | Q30868748 |
| | Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia | Q33594089 |
| | FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage | Q33707858 |
| | Amyloid diseases: abnormal protein aggregation in neurodegeneration | Q33723502 |
| | Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS | Q33889532 |
| | A yeast model of FUS/TLS-dependent cytotoxicity | Q33889537 |
| | Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation. | Q34043216 |
| | Protein aggregation diseases: pathogenicity and therapeutic perspectives | Q34101110 |
| | Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis | Q39054098 |
| | Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. | Q39349822 |
| | Identification and characterization of FUS/TLS as a new target of ATM. | Q39962311 |
| | ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. | Q41036092 |
| | Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles | Q41277254 |
| | Calyculin A, a non-phorbol ester type tumor promotor, induced oxidative DNA damage in stimulated human neutrophil-like cells | Q41407514 |
| | Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins | Q41550219 |
| | Amyloid-like Self-Assembly of a Cellular Compartment | Q41594761 |
| | Pur-alpha functionally interacts with FUS carrying ALS-associated mutations. | Q41880989 |
| | The effects of amino acid composition on yeast prion formation and prion domain interactions | Q41902749 |
| | C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles | Q42380221 |
| | Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy | Q42732668 |
| | Phosphospecific proteolysis for mapping sites of protein phosphorylation | Q44552397 |
| | Sequence Determinants of the Conformational Properties of an Intrinsically Disordered Protein Prior to and upon Multisite Phosphorylation. | Q45408047 |
| | Membraneless organelles can melt nucleic acid duplexes and act as biomolecular filters. | Q48224054 |
| | Sequence- and Temperature-Dependent Properties of Unfolded and Disordered Proteins from Atomistic Simulations. | Q51673743 |
| | Getting Access to Low-Complexity Domain Modifications. | Q51710732 |
| | Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons. | Q52653622 |
| | Phosphorylation-mediated RNA/peptide complex coacervation as a model for intracellular liquid organelles. | Q53305315 |
| | A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. | Q53368534 |
| | Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast? | Q84120968 |
| | PLAAC: a web and command-line application to identify proteins with prion-like amino acid composition | Q34103079 |
| | Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia | Q34125553 |
| | Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms. | Q34155410 |
| | The quantitative proteome of a human cell line. | Q34230963 |
| | The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. | Q34263380 |
| | Functions of FUS/TLS from DNA repair to stress response: implications for ALS. | Q34305789 |
| | Balanced Protein-Water Interactions Improve Properties of Disordered Proteins and Non-Specific Protein Association | Q34503099 |
| | Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity. | Q34507318 |
| | Sequence Determinants of Intracellular Phase Separation by Complex Coacervation of a Disordered Protein | Q34533511 |
| | Self-assembled FUS binds active chromatin and regulates gene transcription. | Q34752975 |
| | The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage | Q34801900 |
| | Regulation of RNA granule dynamics by phosphorylation of serine-rich, intrinsically disordered proteins in C. elegans | Q34975931 |
| | ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons | Q35802889 |
| | Altered mRNP granule dynamics in FTLD pathogenesis. | Q35944221 |
| | Formation and Maturation of Phase-Separated Liquid Droplets by RNA-Binding Proteins | Q36172705 |
| | Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II | Q36172715 |
| | Mutations in FUS cause FALS and SALS in French and French Canadian populations | Q36292149 |
| | ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function | Q36320469 |
| | ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function | Q36548825 |
| | Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost | Q36564221 |
| | Neuronal RNA granules: movers and makers | Q36597037 |
| | RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations | Q36626888 |
| | Stress granules as crucibles of ALS pathogenesis. | Q36804082 |
| | Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss | Q36906420 |
| | ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules | Q36908224 |
| | FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis | Q36922849 |
| | The LC Domain of hnRNPA2 Adopts Similar Conformations in Hydrogel Polymers, Liquid-like Droplets, and Nuclei | Q36934790 |
| | Two prion variants of Sup35p have in-register parallel beta-sheet structures, independent of hydration | Q37348959 |
| | RNA granules: the good, the bad and the ugly | Q37784866 |
| | RNA-binding proteins with prion-like domains in ALS and FTLD-U. | Q37918720 |
| | Protein phosphorylation in neurodegeneration: friend or foe? | Q38214594 |
| | Practical Aspects of Paramagnetic Relaxation Enhancement in Biological Macromolecules | Q38610157 |
| | Phase Separation: Linking Cellular Compartmentalization to Disease. | Q38799797 |
| | Droplet organelles? | Q38881104 |
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 2951-2967 | |
| P577 | publication date | 2017-08-08 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity | |
| P478 | volume | 36 | |